Search results
Results From The WOW.Com Content Network
The medical home, [1] also known as the patient-centered medical home or primary care medical home (PCMH), is a team-based health care delivery model led by a health care provider [2] to provide comprehensive and continuous medical care to patients with a goal to obtain maximal health outcomes.
Patient-centered outcomes focus attention on a patient's beliefs, opinions, and needs in conjunction with a physician's medical expertise and assessment. [1] In the United States , the growth of the healthcare industry has put pressure on providers to see more patients in less time, fill out paperwork in a timely manner, and stay current on the ...
Patient-centered care is a concept that also emphasises the involvement of the patient and their families in the decision making of medical treatments. A main difference is that person-centered care describes the whole person in a wider context rather than the patient-centered approach which is based on the person's role as a patient.
A medical doctor explaining an X-ray to a patient. Several factors help increase patient participation, including understandable and individual adapted information, education for the patient and healthcare provider, sufficient time for the interaction, processes that provide the opportunity for the patient to be involved in decision-making, a positive attitude from the healthcare provider ...
The clinical methods used to help patients clarify and achieve their health-related goals are different for each goal type though the categories are inter-related. [13] The uniting factor of this conceptual framework is that the goal is formed in a discussion involving both the patient and the health care providers prior to the development of a plan of care that is based upon the patient's ...
[9] [10] [2] Patient-centered outcomes research involves questions and outcomes that are "meaningful and important to patients and caregivers" [11] in order to help those individuals make informed decisions for their own care. As of 2019, there have been 65 research standards developed to support patient-centered outcomes research. [12]
The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior line of therapy, including lenalidomide and a proteasome inhibitor.
Additionally, some health conditions, such as for prostate cancer treatment, lack patient-centered outcomes to inform comparative effectiveness research. [ 11 ] While there remains a widespread lack of understanding on the potential impact of CER in the U.S. and a reluctance to fully adopt the concept as part of our healthcare system, research ...